Stephen M. Kelsey (RVMD) files to sell 4,071 restricted shares; prior 4,302 sold
Rhea-AI Filing Summary
Stephen Michael Kelsey filed a Form 144 notice to sell 4,071 shares of Common Stock of Revolution Medicines. The filing lists restricted stock unit grants dated 03/01/2023, 03/01/2024, and 03/01/2025 totaling 4,071 units. It also reports that 4,302 shares were sold on 03/17/2026 for $427,964.68.
Positive
- None.
Negative
- None.
Insights
Notice filed under Form 144 reports proposed resale and a recent sale by an affiliate.
The filing lists 4,071 restricted stock units scheduled for resale and records a prior sale of 4,302 shares on 03/17/2026 for $427,964.68. This is a procedural disclosure under resale rules.
Regulatory implications are routine: transactions reported on Form 144 permit brokered resale under SEC rules when conditions are met. Subsequent trading activity will appear in market or insider filings.